SCHEMBL5606482

SCHEMBL5606482

NOC(=O)/C=C/c1ccc(O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.67
CA7 P43166 6/20 0.67
CA9 Q16790 6/20 0.67
CA14 Q9ULX7 6/20 0.67
CA1 P00915 5/20 0.67
CA2 P00918 4/20 0.67
TYR P14679 3/20 0.67
F3 P13726 2/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
HSD11B1 P28845 1/20 0.61
AKR1B10 O60218 5/20 0.61
AKR1B1 P15121 5/20 0.61
CA4 P22748 3/20 0.59
CA6 P23280 3/20 0.59
CA5A P35218 3/20 0.59
CA5B Q9Y2D0 3/20 0.59
PKM P14618 2/20 0.59
ESR1 P03372 1/20 0.59
CA3 P07451 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10891552 0.83 CA12 (0.71) CA12CA7CA9CA14CA1
SCHEMBL3314742 0.83 CA12 (0.71) CA12CA7CA9CA14CA1
SCHEMBL1860801 0.82 MAPT (0.59) F3CYP2D6CYP2C9AKR1B10AKR1B1
SCHEMBL8496464 0.82 CA12 (0.69) CA12CA7CA9CA14CA1
SCHEMBL1860803 0.82 MAPT (0.59) F3CYP2D6CYP2C9AKR1B10AKR1B1
SCHEMBL23419100 0.81 CA12 (0.73) CA12CA7CA9CA14CA1
SCHEMBL4740380 0.81 CA12 (0.73) CA12CA7CA9CA14CA1
SCHEMBL2033991 0.80 CA12 (0.67) CA12CA7CA9CA14CA1
Methyl P-Hydroxycinnamate SCHEMBL547438 0.80 CA12 (1.00) CA12CA7CA9CA14CA1
SCHEMBL7279950 0.80 CA12 (0.67) CA12CA7CA9CA14CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240229088-A1 POLYAMINE ANALOG PRODUCING YEASTS TECHNICAL UNIVERSITY OF DENMARK (DK) 2024-07-11 US disclosed
CN-114585727-A Yeast for producing polyamine analogs 克里希有限公司 2022-06-03 CN disclosed
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR CA12 463/4885CA7 71/4885CA9 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.